ViiV’s Dolutegravir/Lamivudine FDA Approved for HIV-Positive Adolescents
The U.S. Food and Drug Administration (FDA) has approved the use of Dovato for treating HIV-1 infection in adolescents...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
The U.S. Food and Drug Administration (FDA) has approved the use of Dovato for treating HIV-1 infection in adolescents...
Boundless Bio presents findings from preclinical and clinical studies of BBI-355, a novel inhibitor of checkpoint kinase 1 (CHK1),...
Alterome Therapeutics has developed ALTA-2618, a potent and selective covalent inhibitor targeting the AKT1 E17K mutation found in various...
At the Duke-Margolis Institute for Health Policy conference, industry and government leaders delved into the future of clinical trials...
AltPep Corporation’s SOBA-AD blood test has demonstrated promising accuracy in detecting Alzheimer’s diseaseAlzheimer’s disease (AD) in two independent studies....
Abecma, a personalized CAR T cell therapy, has received expanded approval from the FDA for the treatment of adult...
The KARDIA-2 Phase 2 study evaluated the efficacy and safety of zilebesiran, an RNAi therapeutic targeting hypertension, when added...
Merck has initiated a Phase 3 clinical trial (NCT06345729) to evaluate MK-1084, an oral KRAS G12C inhibitor, in combination...
AngioDynamics has received FDA clearance for the AlphaVac F1885 System to treat pulmonary embolism (PE), a life-threatening condition. PE...
Allurion Technologies has launched its Virtual Care Suite (VCS) in the United States. It provides a comprehensive weight loss...